Washington State University
Washington State University
Explore linked clinical trials.30 results ยท Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nurse-Delivered Brief Pain Relief Skills Treatment in Rural Communities | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Not applicable | 2026-10-07 | NCT07863375 | |
| RVF and Other Emerging Infectious Diseases in East and Central Africa | Bunyaviridae infectious disease, Communicable Diseases, Emerging, Digestive System Diseases, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-10-05 | NCT05139524 | |
| Acute Effects of Cannabis on Cognition and Affect | Chemically-Induced Disorders, cannabis dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07296874 | |
| Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance | Insulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-09-18 | NCT07494084 | |
| C-Protein in Fatigue and Aging | Asthenia, Atrophy, Fatigue, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder | Recruiting | Not applicable | 2026-09-09 | NCT05926219 | |
| Fatigue in Long-Haul Operations | Fatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Not yet recruiting | Not applicable | 2026-08-25 | NCT07761611 | |
| The Tick App: Changing Behaviors With Educational Messaging | Bites and Stings, Chemically-Induced Disorders, Tick Bites, injury, poisoning | Recruiting | Not applicable | 2026-08-13 | NCT06880692 | |
| Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking | Chemically-Induced Disorders, Nicotine Use Disorder, alcohol-related disorders, nicotine dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-07-06 | NCT05181891 | |
| The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study | Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 2 | 2026-07-06 | NCT05134857 | |
| Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment | Stimulant Use Disorder | Recruiting | Phase 2 | 2026-07-02 | NCT06323837 | |
| Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach | Interaction | Recruiting | Early phase 1 | 2026-06-04 | NCT06693960 | |
| Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel | Interaction | Recruiting | Early phase 1 | 2026-06-04 | NCT06692933 | |
| Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac | Interaction | Recruiting | Early phase 1 | 2026-06-04 | NCT06053411 | |
| Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints | Herbal Interaction | Recruiting | Early phase 1 | 2026-06-03 | NCT05846451 | |
| TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) | Alcohol Use Disorder, Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, alcohol-related disorders, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-05-29 | NCT07171359 | |
| Improving Health Outcomes Through Investigations of Wabanaki Food Systems in Maine | Food Insecurity | Recruiting | Not applicable | 2026-05-26 | NCT07561593 | |
| Testing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery (CalmiFy II) | Chemically-Induced Disorders, alcohol-related disorders, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-05-05 | NCT07088237 | |
| Counseling for Harm Reduction and Retention in Medication-assisted Treatment - Cherokee Nation | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-05-05 | NCT05733442 | |
| Using Cognitive-Behavioral Change and Mobile Technology to Improve RN Sleep and Fatigue | Dyssomnias, Fatigue, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sleep Disorders, Intrinsic, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder | Enrolling by invitation | Not applicable | 2026-04-30 | NCT06105307 | |
| Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, cholera, gram-negative bacterial infections, vibrio infectious disease | Recruiting | Phase 4 | 2026-03-23 | NCT07487077 | |
| Effects of Hemp-Derived Cannabinoids on Menopause Symptoms | Fatigue, Mental Fatigue, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, anxiety disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-03-10 | NCT07393672 | |
| FAmily Engagement Strategy for Coordinated Specialty Care | Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder | Recruiting | Not applicable | 2026-02-23 | NCT06945055 | |
| Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Narcotic-Related Disorders, neonatal abstinence syndrome, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-02-05 | NCT04783558 | |
| Natural History Study of Patients With Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency | succinic semialdehyde dehydrogenase deficiency | Recruiting | Not stated | 2026-01-13 | NCT03758521 | |
| Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking | Chemically-Induced Disorders, Dyssomnias, Sleep Disorders, Intrinsic, Substance Use Disorders, insomnia, nervous system disorder, psychiatric disorder, sleep-wake disorder, substance-related disorder | Not yet recruiting | Phase 4 | 2026-01-09 | NCT07328594 |